CHINA

Chongqing Lab

Founded in 2017

Our laboratory in Chongqing, China, established in 2017, provides GxP bioanalytical services. Its core leadership has extensive working experience in the US and China CRO industry.

Lab Description

The site employs 70 scientists operating from 3,500 square meters of purpose-built, state-of-the-art analytical labs.

It is equipped with the world’s most advanced instruments, while its quality assurance system is established in strict accordance with domestic and foreign laws and regulations related to bioanalysis.

The site is the industry leader in China in the bioanalysis of oligonucleotide drugs and mRNA vaccines (PK/PD and ADA), liposomal drug (free and encapsulated drug), ultra-sensitive assays for inhalation drugs, and biomarker assays.

Resolian Bioanalytics Chongqing
Building B9, Dadi Enterprise Park, No. 88 Fenghe Road, Beibei District, Chongqing

Unique Site-specific Expertise

  • Large molecule (LBA & LC-MS) bioanalysis (including oligonucleotides)
  • Ultra-high sensitivity methods
  • qPCR (including mRNA vaccines and BSL-2 [China level])
  • Liposomal drugs (free drug, encapsulated drug and total drug concentrations)
  • Micellar drugs (free drug and total drug concentrations)
  • Lipid drug carriers (PEG20000, PEI25000, PEG2000-DMG, 
Dlin-MC3, ALC-0315 and ALC-0159 etc.)
  • Vitamin D and K analogdrugs (Calcitriol, Alfacalcidol, Eldecalcitol, Paracalcitol, Vitamin K1, Vitamin K2, etc.)
  • Inhalation drugs (Fluticasone, Salmeterol, Indacaterol, Budesonide, Tiotropium, Formoterol, etc.)
  • Ocular drugs

Technology / Platform / Instruments

UHPLC

LC-MS

Immunoassay

Cell & Gene Therapy

Automation

UHPLC

  • Shimadzu Nexera X2
  • LC-30A
  • Shimadzu RF-20Axs FL

LC-MS

  • Sciex 5500 – 6500+
  • Sciex 7500
  • Thermo QE HRMS
  • Agilent 7700 ICP-MS
  • Thermo Q Exactive Plus

Immunoassay

  • MESO QuickPlex SQ 120
  • BioTek Synergy H1Hybrid
  • Multi-Mode Reader
  • NanoDrop One
  • Spectrophotometer
  • Simple Plex Ella

Cell & Gene Therapy

  • BioRad CFX Connect™ qPCR
  • Lungene A200 Thermal
  • Cycler

Automation

  • Tomtec Quadra 4
  • 350 m2 BSL2+ Biosafety and Cell Culture Laboratory

See Our Other Labs

Sandwich Lab

See Sandwich Lab

Malvern Lab

See Malvern Lab

Brisbane Lab

See Brisbane Lab

Fordham Lab (Bioanalytics)

See Fordham Lab (Bioanalytics)

Fordham Lab (Analytical Sciences)

See Fordham Lab (Analytical Sciences)

For the latest news, visit our LinkedIn

Visit LinkedIn

Visit our Events page

Visit Events

Copyright © 2024 Resolian Inc. All rights reserved.

Scroll to Top

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Linkedin

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

Patrick Bennett

Chief Executive Officer

Linkedin

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.